When will Tofacitinib be included in medical insurance and how much will it cost?

In China, Tofacitinib (Tofacitinib) tablets have been approved by the State Food and Drug Administration for marketing, with the trade name Shangjie. Tofacitinib is listed in the new version of the National Medical Insurance Directory< span>It has entered the scope of Class B medical insurance, and the price paid by medical insurance is relatively cheap, butthe reimbursement ratio is different in different regions, and the price after reimbursement will be different.

Tofacitinib is an oral, prescription medication indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (RA), active psoriatic arthritis, ankylosing spondylitis, moderate to severe ulcerative colitis, and children 2 years and older with active polyarticular juvenile idiopathic arthritis. Tofacitinib works by blocking enzymes called Janus kinases (JAKs), which play a role in joint inflammation in rheumatoid arthritis, which can cause pain, swelling and stiffness. This medication is usually given after methotrexate and a tumor necrosis factor inhibitor. Tofacitinib is a pill that takes 5 mg twice a day or 11 mg once a day (extended-release tablets). Tofacitinib can be taken with or without food. People with moderate to severe kidney or liver problems should take lower doses. It is not recommended to use tofacitinib in combination with other disease-modifying biologic antirheumatic drugs (DMARDs) or strong immunosuppressants (such as azathioprine or cyclosporine).

Overseas, there are also generic drugs of tofacitinib produced in other countries. The price of each box produced by a Bangladeshi pharmaceutical factory is around (the price may fluctuate due to the exchange rate). The ingredients of domestic original drugs and foreign generic drugs are basically the same, and the prices of different specifications will be different.